Cardiac Biomarkers Testing Market Projected to Reach $18,232 million by 2026 – Roche, Abbott, Siemens, Becton, Dickinson, Bio-Rad, BioMerieux, PerkinElmer, Tosoh, Danaher, Thermo Fisher
This Report Provides an In-depth Insight of Cardiac Biomarkers Testing Market Industry covering all important parameters including development trends, challenges, opportunities, key manufacturers and competitive analysis.
The global cardiac biomarker market generated $7,638 million in 2018, and is projected to reach $18,232 million by 2026, growing at a CAGR of 11.4%. Cardiac biomarkers are protein-based traceable substances used as an indicator of biologic state as well as for diagnostic and prognostic purposes associated with heart. The prevention of cardiac diseases by monitoring heart conditions via cardiac biomarker testing is the profound approach for obtaining rapid results for immediate diagnosing and treatment. Cardiac biomarkers are used as risk stratification for various cardiovascular diseases (CVDs), which include myocardial infraction, congestive heart failure, acute coronary syndrome (ACS), and others. The cardiac biomarkers that are widely used as an integrated diagnostic approach for CVDs include CK-MB, troponin I and T, myoglobin, BNPs, IMA, and others. The global cardiac biomarkers testing market has witnessed a greater demand over the past five to six years.
Know More|Get Sample Copy of “Cardiac Biomarker Market ” at: https://www.premiummarketinsights.com/sample/AMR00015593
The ability of cardiac markers for accurate and rapid prediction of heart failure after the onset of chest pain acts as a key factor that boosts the growth of the global cardiac market. In addition, promising features such as high accuracy, quick outcomes, and economic pricing of cardiac point of care (POC) testing drive the market growth. To keep the momentum of cardiac marker tests, key manufacturers offer customized solutions, thus propelling the growth of the market. The commercial application of multi-menu options for cardiac testing using different combinations of cardiac biomarkers and target-oriented solutions serves as the key opportunity for market expansion. However, limited specificity in some cases and side effects such as skeletal muscle injury restrain the growth of the cardiac biomarkers testing market.
The global cardiac biomarker market is segmented based on type, application, location of testing, and region. By type, the market is fragmented into myocardial muscle creatine kinase (CK-MB), troponins (T and I), myoglobin, brain natriuretic peptide (BNPs) or NT-proBNP, ischemia modified albumin (IMA), and others. Depending on application, it is categorized into myocardial infarction, congestive heart failure, acute coronary syndrome, atherosclerosis, and others. By location of testing, it is bifurcated into point of care testing and laboratory testing. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Check for Discount at: https://www.premiummarketinsights.com/discount/AMR00015593
Table of Contents:
CHAPTER 2:EXECUTIVE SUMMARY
CHAPTER 3:MARKET OVERVIEW
CHAPTER 4: CARDIAC BIOMARKER TESTING MARKET, BY TYPE
CHAPTER 5: CARDIAC BIOMARKER TESTING MARKET, BY APPLICATION
CHAPTER 6: CARDIAC BIOMARKER TESTING MARKET, BY LOCATION OF TESTING ]
CHAPTER 7: CARDIAC BIOMARKER TESTING MARKET, BY REGION
CHAPTER 8: COMPANY PROFILES
Get Complete Report at: https://www.premiummarketinsights.com/buy/AMR00015593
Name: Sameer Joshi
Email: [email protected]
Organization: Premium Market Insights
About Premium Market Insights:
Premium Market Insights is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers. We provide best in class customer service and our customer support team is always available to help you on your research queries. Our commitment to customer service is best exemplified by free analyst support that we offer to our clients which sets us apart from any other provider.